The Global Contraceptive Devices Market was valued at US$ 7,013.8 Mn in 2017 and is projected to reach US$ 11,166.4 Mn by 2025, exhibiting a CAGR of 6.0% in the forecast period (2018-2025).
Contraceptives devices for female are expected to lead the contraceptives devices market during the forecast period. Contraceptive devices for female are available in different types, among which the report emphasizes on the rising uptake of intrauterine contraceptive devices. Some of these include diaphragms & sponges, vaginal rings, sub-dermal implants, and female condoms.
Consequently, the sales of female contraceptive devices are accelerating at an exponential rate. As per Fortune Business Insights, the female contraceptive devices segment held nearly 54.8% of the overall Contraceptive Devices Market in the year 2017 and is expected to remain dominant over the forecast years.
Speak to Analyst@ https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/contraceptive-devices-market-100062
Company profiled in this report based on Business overview, Financial data, Product landscape, Strategic outlook & SWOT analysis:
• Bayer AG
• Pfizer Inc.
• Janssen Pharmaceuticals, Inc.
• Teva Pharmaceutical Industries Ltd.
• Merck & Co., Inc.
• Mylan N.V.
• Allergan
• Reckitt Benckiser Group plc
• Veru Inc.
• Church & Dwight Co., Inc.
• Medisafe Distribution Inc.
“Initiatives by Several Players Aimed at Sustaining Competitive Advantage to Bode Well”
Some of the key players present in the global contraceptives devices market are Janssen Pharmaceutical Company, Allergan plc, Veru Inc., Pfizer Inc., Teva Pharmaceuticals Industry, Mylan, Medisafe Distribution Inc., and Reckitt Benckiser plc. Several companies are taking initiatives to sustain in their competitiveness in the market for contraceptive devices. Furthermore, companies are creating awareness programs to encourage the use of contraceptives.
These companies also provide different types of birth control devices at affordable rates to maintain their market share. For instance, Tera Pharmaceuticals in November 2017 signed an agreement with another company called CopperSurgical with an aim to acquire an intrauterine copper contraceptive called Paragard. Such strategies adopted by the leading players are expected to boost the global contraceptive devices market in the coming years.
Market Segmentations:
By Technology
• Hormonal Contraceptives
• Barrier Contraceptives
By Distribution Channel
• Hospital Pharmacy
• Retail Pharmacy
• Clinics
• Online Channels
• Public Channel & NGO
Order Full Report@ https://www.fortunebusinessinsights.com/checkout-page/100062
“Lack of Proper Family Planning Will Fuel Demand for Contraceptive Devices”
“The demand for contraceptive devices and drugs is likely to increase owing to the rising prevalence of STDs,” stated a lead analyst at FBI. These include injectable contraceptives, hormonal oral pills, and topical contraceptives. “This, coupled with the lack of family planning, drives the contraceptive devices market,” he added. Furthermore, unwanted pregnancies can have widespread implications. This is further expected to increase the requirement of fertility control devices over the upcoming years.
In addition to this, the rapid growth in population across the world is anticipated to enable contraceptives market witness accelerated gains. Several companies are increasing awareness on the use and safety of contraceptive devices. This is also considered as a growth factor driving the contraceptive devices market. These devices are preferred more as they offer a safer course of action. All the above factors are anticipated to witness promising growth in the contraceptive devices market between 2018 and 2025.
“Adverse Effects of Contraceptives and their Limited Supply May Restrict the Market’s Growth”
Although the use of contraceptives is increasing, there are some risks associated with the use of the same. These risks include infections which compe people to opt for permanent contraception methods. Also, there are millions of men and women who don’t use contraceptive devices owing to their limited supply. Not all countries have access to contraception, which limits the growth of the contraceptive devices market.
Table of Content:
1. Introduction
1.1. Research Scope
1.2. Market Segmentation
1.3. Research Methodology
1.4. Definitions and Assumptions
2. Executive Summary
3. Market Dynamics
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
4. Key Insights
4.1 Fertility Statistics – Key Countries, 2017
4.2 New Product Launch
4.3 Key Industry Trends
4.4 Regulatory Scenario – Key Countries
4.5 Key Technological Advancements
4.6 Recent Industry Developments – Partnerships, Mergers & Acquisitions
